home.aspx
 
EVENTS

The Digital Pharma Advances
THE DIGITAL PHARMA ADVANCES
January 29-29, 2020
Powerfully Target & Engage HCPs & Patients & Deliver Real-World Results With Integrated, Innovative Digital Strategies.Customer-Centric, Value-Adding, Multi-Channel Digital Pharma Marketing Strategies.

4th Annual Microbiome Movement, Drug Development, Europe
4TH ANNUAL MICROBIOME MOVEMENT, DRUG DEVELOPMENT, EUROPE
February 04-05, 2020
As the first microbiome-based therapeutic steps closer to market approval, the scientific community continue to demonstrate the functional role of the human microbiome as a novel source of therapeutic, biomarker and diagnostic development. Despite this progress, the vast potential to develop effecti...

Biotest Pharmaceuticals Corporation

SHARESHARESHARE
Biotest Pharmaceuticals researches and manufactures biotherapeutic products with a specialization in immunology and hematology.
SHARESHARESHARE

RELATED NEWS


Its becoming a familiar refrain- Women are making headway in the workplace. In 2019, more women are serving in Congress than ever before, and various industries the life sciences included are well into implementing programs to boost diversity. Hows pharma doing. By one measure, pretty well. The biggest pharma companies on the London Stock Exchange nearly tripled the number of women on their executive committees between 2018 and 2019. But that sort of progress didn't extend to all top job tit...

READ MORE

After six years of legal wrangling and unflattering headlines, Novartis appears close to putting a doctor kickback lawsuit behind it—and the revelation came from a court filing that was supposed to be kept secret. The whistleblower suit against Novartis, joined by the U.S. Department of Justice (DOJ) in 2013, claimed the drugmaker used sham educational events as cover for kickbacks to doctors. In exchange for fancy dinners, fishing trips and other entertainment, Novartis was basically buyi...

READ MORE

Two of AstraZenecas most important drugs have received a boost, after European regulators backed a pen allowing people to inject themselves with respiratory drug Fasenra, and agreed that cardiovascular benefits data could be added to the label of diabetes drug Forxiga. The European Medicines Agency’s CHMP regulatory committee gave a positive opinion to add a self-administration option for asthma injection Fasenra (benralizumab), based on a new delivery method as a pre-filled, single-use au...

READ MORE

Bayer and Johnson & Johnson have agreed to settle more than 25,000 US lawsuits worth more than $775 million alleging that blockbuster blood thinner Xarelto caused unstoppable and sometimes fatal bleeding, the latest in a string of similar legal agreements involving this class of drugs. Developed in partnership with Johnson & Johnson, Xarelto is Bayer’s best-selling drug, contributing 3.6 billion euros in revenue to the German company’s pharma business in 2018. J&J markets...

READ MORE

A new law will soon mandate pharmaceutical manufacturing companies that either sell or distribute medications to provide Massachusetts residents with more opportunities to dispose unused, unwanted pills. The aim is to reduce the ubiquity prescription medication as the state grapples with an epidemic of substance abuse. The entirely new chapter added to Massachusetts General Laws was part of the opioid bill, "An Act relative to Substance Abuse, Use, Treatment, Education and Prevention," signed by...
WICKEDLOCAL.COM
READ MORE

The American Pharmacists Association (APhA) has developed a resource guide designed to incorporate immunization services into pharmacy practice settings based on the JCPP Pharmacists’ Patient Care Process (PPCP). Pharmacists are integral members of the immunization neighborhood and have positioned immunization services as an important patient care offering....

READ MORE

EVENTS

The Digital Pharma Advances
THE DIGITAL PHARMA ADVANCES
January 29-29, 2020
Powerfully Target & Engage HCPs & Patients & Deliver Real-World Results With Integrated, Innovative Digital Strategies.Customer-Centric, Value-Adding, Multi-Channel Digital Pharma Marketing Strategies.

4th Annual Microbiome Movement, Drug Development, Europe
4TH ANNUAL MICROBIOME MOVEMENT, DRUG DEVELOPMENT, EUROPE
February 04-05, 2020
As the first microbiome-based therapeutic steps closer to market approval, the scientific community continue to demonstrate the functional role of the human microbiome as a novel source of therapeutic, biomarker and diagnostic development. Despite this progress, the vast potential to develop effecti...